Browse > Article
http://dx.doi.org/10.13103/JFHS.2018.33.3.151

Marine Algae and Their Potential Application as Antimicrobial Agents  

Charway, Grace N.A. (Inland and Aquaculture Division, Fisheries Commission, Ministry of Fisheries and Aquaculture Development)
Yenumula, Padmini (Department of Food Science and Technology, Pukyong National University)
Kim, Young-Mog (Inland and Aquaculture Division, Fisheries Commission, Ministry of Fisheries and Aquaculture Development)
Publication Information
Journal of Food Hygiene and Safety / v.33, no.3, 2018 , pp. 151-156 More about this Journal
Abstract
The world is becoming overwhelmed with widespread diseases as antibiotic resistance increases at an alarming rate. Hence, there is a demanding need for the discovery and development of new antimicrobial drugs. The ocean is gifted with many organisms like phytoplankton, algae, sponges, cnidarians, bryozoans, mollusk, tunicates and echinoderms, which are known to produce a wide variety of bioactive secondary metabolites with pharmacological properties. Many new therapeutic drugs have emerged from marine invertebrates, although the large algal community is yet to be explored. The bioactivity possessing secondary metabolites of marine algae include polyphenols, phlorotannins, alkaloids, halogenated compounds, sulfated polysaccharides, agar, carrageenan, proteoglycans, alginate, laminaran, rhamnan sulfate, galactosylglycerol, and fucoidan. These metabolites have been found to have great antimicrobial activities against many human aliments. Studies show that the algal community represents about 9% of biomedical compounds obtained from the sea. This review looks at the evolution of drugs from the ocean, with a special emphasis on the antimicrobial activities of marine algae.
Keywords
Antimicrobial effect; Bioactive secondary metabolites; Marine algae;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Manilal A., Sujith S., Selvin J., Shakir C., Seghal G.: Antibacterial activity of Falkenbergiahillebrandii (Born) from the Indian coast against human pathogens. Int. J. Exp. Bot., 78, 161-166, (2009).
2 Etahiri S., Bultel-Ponce V., Caux C., Guyot M.: New bromoditerpenes from the red alga Sphaerococcuscoronopifolius. J. Nat. Prod., 64, 1024-1027 (2001).   DOI
3 Cueto M., Jensen P.R., Kauffman P., Fenical W., Lobkovsky E., Clardy J.: Pestalone a new antibiotic produced by a marine fungus in response to bacterial challenge. J. Nat. Prod., 64, 1444-1446 (2001).   DOI
4 Beress A., Wassermann O., Tahhan S., BruhnT., Beress L., Kraiselburd E.N., Gonzalez L.V., de Motta G.E., Chavez P.I.: A new procedure for the isolation of anti-HIV compounds (polysaccharides and polyphenols) from the marine alga Fucusvesiculosus. J. Nat. Prod., 56, 478-488 (1993).   DOI
5 Eom S.H., Lee D.S., Kang Y.M., Son K.T., Jeon Y.J., Kim Y.M.: Application of yeast Candida utilis to ferment Eiseniabicyclis for enhanced antibacterial effect. Appl. Biochem. Biotechnol., 171, 569-582 (2013).   DOI
6 Perez R.M., Avila J.G., Perez S., Martinez A., Martinez G.: Antimicrobial activity of some American algae. J. Ethnopharmacol., 29, 111-116 (1990).   DOI
7 Albuquerque M.R., Takaki C., Koening M.L.: Detection of antimicrobial activity in marine seaweeds. Rev.Inst. Antibiot. Univ. Fed. Pernambuco Recife., 21, 127-138 (1983).
8 Choi J.G., Kang O.H., Brice O.O., Lee Y.S., Chae H.S., Oh Y.C., Sohn D.H., Park H., Choi H.G., Kim S.G., Shin D.W., Kwon D.Y.: Antibacterial activity of Ecklonia cava against methicillin-resistant Staphylococcus aureus and Salmonella spp. Foodborne Pathog. Dis., 7, 435-441 (2010).   DOI
9 Lee M.H., Lee K.B., Oh S.M., Lee B.H., Chee H.Y.: Antifungal activities of dieckol isolated from the marine brown alga Ecklonia cava against Trichophyton rubrum. Food Sci. Biotechnol., 53, 504-507 (2010).
10 Alarif W.M., Al-Lihaibi S.S., Ayyad S.E., Abdel-Rhman M.H., Badria F.A.: Laurene-type sesquiterpenes from the Red Sea red alga Laurenciaobtusa as potential antitumoreantimicrobial agents. Eur. J. Med. Chem., 55, 462-466 (2012).   DOI
11 da Silva Machado F.L., Pacienza-Lima W., Rossi-Bergmann B., de Souza Gestinari L.M., Fujii M.T. de Paula J.C., Costa S.S., Lopes N.P., Kaiser C.R., Soares, A.R.: Antileishmanialsesquiterpenes from the brazilian red alga Laurenciadendroidea. Planta Med., 77, 733-735 (2011).   DOI
12 dos Santos A.O., Britta E.A., Bianco E.M., Ueda-Nakamura T., Filho B.P., Pereira R.C., Nakamura C.V.: 4-Acetoxydolastane diterpene from the Brazilian brown alga Canistrocarpuscervicornis as antileishmanial agent. Mar. Drugs, 9, 2369-2383 (2011).   DOI
13 Bourgougnon N., Lahaye M., Quemener B., Chermann J.C., Rimbert M., Cormaci M., Furnari G., Komprobst J.M.: Annual variation in composition and in vitro anti-HIV-1 activity of the sulfated glucuronogalactan from Schizymeniadubyi (Rhodophyta, Gigartinales). J. Appl. Phycol., 8, 155-161 (1996).   DOI
14 dos Santos A.O., Veiga-Santos P., Ueda-Nakamura T., Sudatti D.B., Bianco E.M., Pereira R.C., Nakamura C.V.: Effect of elatol, isolated from red seaweed Laurenciadendroidea, on Leishmaniaamazonensis. Mar. Drugs, 8, 2733-2743 (2010).   DOI
15 Soares D.C., Calegari-Silva T.C., Lopes U.G., Teixeira V.L., de Palmer Paixao I.C.N., Cirne-Santos C., Bou-Habib D.C., Saraiva E.M.: Dolabelladienetriol, a compound from Dictyotapfaffii algae, inhibits the infection by Leishmaniaamazonensis. PLOS Neglect. Trop. D., 6, e1787 (2012)   DOI
16 Takamatsu S., Hodges T.W., Rajbhandari I., Gerwick W.H., Hamann M.T., Nagle D.G.: Marine natural products as novel antioxidant prototypes. J. Nat. Prod., 66, 605-608 (2003).   DOI
17 Woolner V.H., Jones C.M., Field J.J., Fadzilah N.H., Munkacsi A.B., Miller J.H., Keyzers R.A., Northcote P.T.: Polyhalogenated indoles from the red alga Rhodophyllis-membranacea: The first isolation of bromo-chloro-iodo secondary metabolites. J. Nat. Prod., 79, 463-469 (2016).   DOI
18 de Sousa A.P.A., Torres M.R., Pessoa C., deMoraes M.O., Filho F.D.R., Alves A.P.N.N., Costa-Lotufo L.V.: In vivo growth-inhibition of sarcoma 180 tumor by alginates from brown seaweed Sargassum vulgare. Carbohydr. Polym., 69, 7-13 (2007).   DOI
19 Gerwick W.H., Fenical W.: Ichthyotoxic and cytotoxic metabolites of the tropical brown alga, Stypopodiumzonale. J. Org. Chem., 46, 22-27 (1981).   DOI
20 Rajasulochana P., Krishnamoorthy P., Dhamotharan R.: Isolation, identification of bromophenol compound and antibacterial activity of Kappaphycus sp. Int. J. Pharm. Bio. Sci., 3, 173-186 (2012).
21 Suzgec-Selcuk S., Mericli A.H., Guven K.C., Kaiser M., Casey R., Hingley-Wilson S., Lalvani A., Tasdemir D.: Evaluation of Turkish seaweeds for antiprotozoal, antimycobacterial and cytotoxic activities. Phytother. Res., 25, 778-783 (2011).   DOI
22 Veiga-Santos P., Pelizzaro-Rocha K.J., Santos A.O., Ueda-Nakamura T., Dias Filho B.P., Silva S.O., Sudatti D.B., Bianco E.M., Pereira R.C., Nakamura C.V.: In vitro anti-trypanosomal activity of elatol isolated from red seaweed Laurenciadendroidea. Parasitology, 137, 1661-1670 (2010).   DOI
23 Vonthron-Senecheau C., Kaiser M., Devambez I., Vastel A., Mussio I., Rusig A.M.: Antiprotozoal activities of organic extracts from French marine seaweeds. Mar. Drugs, 9, 922-933 (2011).   DOI
24 Galle J.B., Attioua B., Kaiser M., Rusig A.M., Lobstein A., Vonthron-Senecheau C.: Eleganolone, a diterpene from the French marine alga Bifurcariabifurcata inhibits growth of the human pathogens Trypanosoma brucei and Plasmodium falciparum. Mar. Drugs, 11, 599-610 (2013).   DOI
25 de Felicio R., de Albuquerque S., Young M.C., Yokoya N.S., Debonsi H.M.: Trypanocidal, leishmanicidal and antifungal potential from marine red alga Bostrychiatenella J. Agardh (Rhodomelaceae, Ceramiales). J. Pharm. Biomed. Anal., 52, 763-769 (2010).   DOI
26 Meiyu G., Fuchuan L., Xianliang X., Jing L., Zuowei Y., Huashi G.: The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule. Antiviral Res., 59, 127-135 (2003).   DOI
27 Torres F.A.E., Passalacqua T.G., Velasquez A.M.A., Souza R.A., Colepicolo P., Graminha M.A.S.: New drugs with antiprotozoal activity from marine algae: a review. Rev. Bras. Farmacog., 24, 265-276 (2014).   DOI
28 Carter G.T., Rinehart K.L. Jr., Li L.H. Kuentzel S.L., Connor J.L.: Brominated indoles from Laurenciabrongniartii. Tetrahedron Lett., 46, 4479-4482 (1978).
29 Perez M.J., Falque E., Dominguez H.: Antimicrobial action of compounds from marine seaweed. Mar. Drugs, 14, E52 (2016).   DOI
30 Richards J.T., Kern E.R., Glasgow L.A., Overall J.C. Jr., Deign E.F., Hatch M.T.: Antiviral activity of extracts from marine algae. Antimicrob. Agents Chemother., 14, 24-30 (1978).   DOI
31 Demirel Z., Yilmaz-Koz F.F., Karabay-Yavasoglu U.N., Ozdemir G., Sukatar A.: Antimicrobial and antioxidant activity of brown algae from the Aegean Sea. J. Ser. Chem. Soc., 74, 619-628 (2009).   DOI
32 Guedes A.C., Barbosa C.R., Helena M.A., Claudia I.P., Francisco, X.M.: Microalgal and cyanobacterial cell extracts for use as natural antibacterial additives against food pathogens. Int. J. Food Sci. Technol., 46, 862-870 (2011).   DOI
33 Eom S.H., Kim Y.M., Kim S.K.: Antimicrobial effect of phlorotannins from marine brown algae. Food Chem. Toxicol., 50, 3251-3255 (2012).   DOI
34 Cavallo R.A., Acquaviva M.I., Stabili L., Cecere E., Petrocelli A., Narracci M.: Antibacterial activity of marine macroalgae against fish pathogenic Vibrio species. Cent. Eur. J. Biol., 8, 646 (2013).
35 Bhagavathy S., Sumathi P., Jancy Sherene Bell I.: Green algae Chlorococcumhumicola a new source of bioactive compounds with antimicrobial activity. Asian Pac. J. Trop. Biomed., 1, S1-7 (2011).   DOI
36 Plaza M., Santoyo S., Jaime L, Garcia-Blairsy R.G., Herrero M., Senorans F.J., Ibanez E.: Screening for bioactive compounds from algae. J. Pharm. Biomed. Anal., 51, 450-455 (2010).   DOI
37 Schaeffer D.J., Krylov V.S.: Anti-HIV activity of extracts and compounds from algae and cyanobacteria. Ecotoxicol. Environ. Saf., 45, 208-227 (2000).   DOI
38 Witvrouw M., De Clercq E.: Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Gen. Pharmacol., 29, 497-511 (1997).   DOI
39 Ponce N.M., Pujol C.A., Damonte E.B., Flores M.L., Stortz C.A.: Fucoidans from the brown seaweed Adenocystisutricularis: extraction methods, antiviral activity and structural studies. Carbohydr. Res., 338, 153-165 (2003).   DOI
40 Pujol C.A., Estevez J.M., Carlucci M.J., Ciancia M., Cerezo A.S., Damonte E.B.: Novel DL-galactan hybrids from the red seaweed Gymnogongrustorulosus are potent inhibitors of herpes simplex virus and dengue virus. Antivir. Chem. Chemother., 13, 83-89 (2002).   DOI
41 Thompson K.D.Dragar C.: Antiviral activity of Undariapinnatifida against herpes simplex virus. Phytother. Res., 18, 551-555 (2004).   DOI
42 Ono L., Wollinger W., Rocco I.M., Coimbra T.L., Gorin P.A., Sierakowski M.R.: In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain). Antiviral Res., 60, 201-208 (2003).   DOI
43 Davyt D., Entz W., Fernandez R., Mariezcurrena R., Mombru A.W., Saldana J., Dominguez L., Coll J., Manta E.: A new indole derivative from the red alga Chondriaatropurpurea. Isolation, structure determination, and anthelmintic activity. J. Nat. Prod., 61, 1560-1563 (1998).   DOI
44 Talarico L.B., Pujol C.A., Zibetti R.G., Faria P.C., Noseda M.D., Duarte M.E., Damonte E.B.: The antiviral activity of sulfated polysaccharides against dengue virus is dependent on virus serotype and host cell. Antiviral Res., 66, 103-110 (2005).   DOI
45 Donia M., Hamann M.T.: Marine natural products and their potential applications as anti-infective agents. Lancet Infect. Dis., 6, 338-348 (2003).
46 Lie J., Zhou J.: A marine natural product database. J. Chem. Inf. Comput. Sci., 42, 742-748 (2002).   DOI
47 Barbosa M., Valentao P., Andrade P.B.: Bioactive compounds from macroalgae in the new millennium: implications for neurodegenerative diseases. Mar. Drugs, 12, 4934-4972 (2014).   DOI
48 Farias W.R., Valente A.P., Pereira M.S., Mourao P.A.: Structure and anticoagulant activity of sulfated galactans. Isolation of a unique sulfated galactan from the red algae Botryocladiaoccidentalis and comparison of its anticoagulant action with that of sulfated galactans from invertebrates. J. Biol. Chem., 275, 29299-2307 (2000).   DOI
49 Nuijen B., Bouma M., Talsma H., Manada C., Jimeno J.M., Lopez-Lazaro L., Bult A., Beijnen J.H.: Development of a lyophilized parenteral pharmaceutical formulation of the investigational polypeptide marine anticancer agent kahalalide F. Drug Dev. Ind. Pharm., 27, 767-780 (2000).
50 Palermo J.A., Flower B.P., Seldes A.M.: Chondriamides A and B new indolic metabolites from red algae Chondria sp. Tetrahedron Lett., 33, 3097-3100 (1992).   DOI
51 Hidari K.I., Takahashi N., Arihara M., Nagaoka M., Morita K., Suzuki T.: Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga. Biochem. Biophys. Res. Commun., 376, 91-95 (1981).
52 Shibata T., Fujimoto K., Nagayama K., Yamaguchi K., Nakamura T.: Inhibitory activity of brown algal phlorotannins against hyaluronidase. Int. J. Food Sci. Tech., 37, 703-709 (2002).   DOI
53 Bernardi G. and Springer G.F.: Properties of highly purified fucan. J. Biol. Chem., 237, 75-80 (1962).
54 Yuan H., Song J., Li X., Li N., Dai J.: Immunomodulation and antitumor activity of ${\kappa}$-carrageenan oligosaccharides. Cancer Lett., 243, 228-234 (2006).   DOI